Sagimet Biosciences is a clinical-stage biotechnology company focused on developing therapeutics for metabolic and fibrotic diseases. Its research programs include small-molecule candidates targeting pathways involved in liver and other chronic diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!